In addition to its role of immunosuppression via regulating PD-1 expression in macrophages surrounding breast cancer cells (26), CCL2 may also influence breast cancer cell proliferation and cell-cycle progression through SRC and PKC activation (27). The gene discussed is SRC; the disease is breast carcinoma.